Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
23.63
+0.52 (2.25%)
At close: Apr 22, 2026, 4:00 PM EDT
23.68
+0.05 (0.21%)
Pre-market: Apr 23, 2026, 8:40 AM EDT
Bicara Therapeutics Employees
Bicara Therapeutics had 103 employees as of December 31, 2025. The number of employees increased by 48 or 87.27% compared to the previous year.
Employees
103
Change (1Y)
48
Growth (1Y)
87.27%
Revenue / Employee
n/a
Profits / Employee
-$1,339,320
Market Cap
1.55B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | 48 | 87.27% |
| Dec 31, 2024 | 55 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 711 |
| Agios Pharmaceuticals | 540 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Biohaven | 274 |
| Viridian Therapeutics | 252 |
| AnaptysBio | 104 |
| Nanobiotix | 103 |
BCAX News
- 20 days ago - Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 24 days ago - Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Bicara Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Business Updates on March 30, 2026, at 8:30 AM ET - GlobeNewsWire
- 7 weeks ago - Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 2 months ago - Bicara Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - Bicara Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - Bicara Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen - GlobeNewsWire